Cushing’s syndrome in type 2 diabetes patients with poor glycemic control

Endocrine

Volumn 47, Issue 3, 2014, Pages 895-900

  Gungunes, Askin ^a   Sahin, Mustafa ^b   Demirci, Taner ^a   Ucan, Bekir ^a   Cakir, Evrim ^a   Arslan, Muyesser Sayki ^a   Unsal, Ilknur Ozturk ^a   Karbek, Basak ^a   Calıskan, Mustafa ^a   Ozbek, Mustafa ^a   Cakal, Erman ^a   Delibasi, Tuncay ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Cushing s syndrome; Insulin therapy; Type 2 diabetes

Indexed keywords

HYDROCORTISONE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGE; AGED; ARTICLE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FEMALE; GLYCEMIC CONTROL; HORMONE DETERMINATION; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; VERY ELDERLY; BLOOD; COMORBIDITY; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COMORBIDITY; CUSHING SYNDROME; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE;

EID: 84911952125     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0260-8     Document Type: Article

References (28)

1. J. Newell-Price, X. Bertagna, A.B. Grossman, L.K. Nieman, Cushing’s syndrome. Lancet 367, 1605–1617 (2006)
2. C. Steffensen, A.S. Bak, K.Z. Rubeck, J.O.L. Jorgensen, Epidemiology of Cushing’s syndrome. Neuroendocrinology 92(suppl. 1), 1–5 (2010)
3. B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88, 5808–5813 (2003)
4. G. Leibowitz, A. Tsur, S.D. Chayen, M. Salameh, I. Raz, E. Cerasi, D.J. Gross, Pre-clinical Cushing’s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 44(6), 717–722 (1996)
5. I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur. J. Endocrinol. 153(6), 837–844 (2005)
6. M. Sahin, L. Kebapcilar, A. Taslipinar, O. Azal, T. Ozgurtas, A. Corakci, E.O. Akgul, M.Y. Taslipinar, M. Yazici, M. Kutlu, Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing’s syndrome in obese patients. Intern. Med. 48(1), 33–39 (2009)
7. G. Mazziotti, C. Gazzaruso, A. Giustina, Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol. Metab. 22(12), 499–506 (2011)
8. R. Giordano, F. Guaraldi, R. Berardelli, I. Karamouzis, V. D’Angelo, E. Marinazzo, A. Picu, E. Ghigo, E. Arvat, Glucose metabolism in patients with subclinical Cushing’s syndrome. Endocrine 41(3), 415–423 (2012). Review
9. Guidelines Committee European Society of Hypertension, European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 21, 1011–1053 (2003)
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285, 2486–2497 (2001)
11. S. Newsome, K. Chen, J. Hoang, J.D. Wilson, J.M. Potter, P.E. Hickman, Cushing’s syndrome in a clinic population with diabetes. Intern Med J 38(3), 178–182 (2008)
12. H. Liu, D.M. Bravata, J. Cabaccan, H. Raff, E. Ryzen, Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxf) 63(6), 642–649 (2005)
13. L. Gagliardi, I.M. Chapman, P. O’Loughlin, D.J. Torpy, Screening for subclinical Cushing’s syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol. Horm. Metab. Res. 42(4), 280–284 (2010)
14. K. Mullan, N. Black, A. Thiraviaraj, P.M. Bell, C. Burgess, S.J. Hunter, D.R. McCance, H. Leslie, B. Sheridan, A.B. Atkinson, Is there value in routine screening for Cushing’s syndrome in patients with diabetes? J. Clin. Endocrinol. Metab. 95(5), 2262–2265 (2010)
15. M. Terzolo, G. Reimondo, I. Chiodini, R. Castello, R. Giordano, E. Ciccarelli, P. Limone, C. Crivellaro, I. Martinelli, M. Montini, O. Disoteo, B. Ambrosi, R. Lanzi, M. Arosio, S. Senni, A. Balestrieri, E. Solaroli, B. Madeo, R. De Giovanni, F. Strollo, R. Battista, A. Scorsone, V.A. Giagulli, D. Collura, A. Scillitani, R. Cozzi, M. Faustini-Fustini, A. Pia, R. Rinaldi, B. Allasino, G. Peraga, F. Tassone, P. Garofalo, E. Papini, G. Borretta, Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. J. Clin. Endocrinol. Metab. 97(10), 3467–3475 (2012)
16. A. Tabarin, P. Perez, Pros and cons of screening for occult Cushing syndrome. Nat Rev Endocrinol 7, 445–455 (2011)
17. T. Taniguchi, A. Hamasaki, M. Okamoto, Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus. Endocr. J. 55(2), 429–432 (2008)
18. G. Reimondo, A. Pia, B. Allasino, F. Tassone, S. Bovio, G. Borretta, A. Angeli, M. Terzolo, Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67(2), 225–229 (2007)
19. C. Cronin, D. Igoe, M.J. Duffy, S.K. Cunningham, T.J. McKenna, The overnight dexamethasone test is a worthwhile screening procedure. Clin Endocrinol (Oxf) 33, 27–33 (1990)
20. L. Kennedy, A.B. Atkinson, H. Johnston, B. Sheridan, D.R. Hadden, Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing’s syndrome. Br. Med. J. 289, 1188–1191 (1984)
21. J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 43, 545–550 (1995)
22. C. Di Somma, R. Pivonello, S. Loche, A. Faggiano, P. Marzullo, A. Di Sarno, M. Klain, M. Salvatore, G. Lombardi, A. Colao, Severe impairment of bone mass and turnover in Cushing’s disease: comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol (Oxf) 56, 153–158 (2002)
23. L. Tauchmanovà, R. Pivonello, C. Di Somma, R. Rossi, M.C. De Martino, L. Camera, M. Klain, M. Salvatore, G. Lombardi, A. Colao, Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J. Clin. Endocrinol. Metab. 91, 1779–1784 (2006)
24. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)
25. J. Newell-Price, P. Trainer, M. Besser, A. Grossman, The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr. Rev. 19, 647–672 (1998)
26. M. Boscaro, L. Barzon, N. Sonino, The diagnosis of Cushing’s syndrome: atypical presentations and laboratory shortcomings. Arch. Intern. Med. 160, 3045–3053 (2000)
27. H. Raff, Update on late-night salivary cortisol for the diagnosis of Cushing’s syndrome: methodological considerations. Endocrine. 44(2), 346–349 (2013)
28. Z.E. Belaya, A.V. Iljin, G.A. Melnichenko, L.Y. Rozhinskaya, N.V. Dragunova, L.K. Dzeranova, S.A. Butrova, E.A. Troshina, I.I. Dedov, Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine. 41(3), 494–500 (2012)